Nyxoah announced the appointment of Francis Kim as chief regulatory and quality officer. Francis will be leading Nyxoah’s global regulatory and quality departments. Kim is a global regulatory and quality executive in the healthcare industry, having spent more than 25 years in the medical device and life sciences sector.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NYXH:
- Nyxoah Strengthens its Executive Leadership Team
- Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Nyxoah reports Q3 EPS EUR .26 vs EUR .24 last year
- Nyxoah Reports Third Quarter 2023 Financial and Operating Results
- Nyxoah to Participate in the Jefferies London Healthcare Conference
